Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2024-2031

Report ID: 934137 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 HEPtune® Technology
        1.2.3 Intravail® Technology
        1.2.4 RapidMist™
        1.2.5 TheraKine Technology
        1.2.6 Arestat™ Technology
        1.2.7 DelSiTech™ Silica Matrix
        1.2.8 ImSus® Technology
        1.2.9 PLEX™ Technology
        1.2.10 ENHANZE® Technology
    1.3 Market by Application
        1.3.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Delivery of Protein
        1.3.3 Delivery of Nucleic Acids
        1.3.4 Delivery Antibody
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Perspective (2016-2027)
    2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Trends by Regions
        2.2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Share by Regions (2016-2021)
        2.2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2022-2027)
    2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Industry Dynamic
        2.3.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Trends
        2.3.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Drivers
        2.3.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Challenges
        2.3.4 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Revenue
        3.1.1 Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Revenue (2016-2021)
        3.1.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Players (2016-2021)
    3.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue
    3.4 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio
        3.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2020
    3.5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players Head office and Area Served
    3.6 Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service
    3.7 Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Breakdown Data by Type
    4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Size by Type (2016-2021)
    4.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Type (2022-2027)

5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Breakdown Data by Application
    5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Historic Market Size by Application (2016-2021)
    5.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
    6.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
        6.2.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
        6.2.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
        6.2.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
    6.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
        6.3.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
        6.3.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
        6.3.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
    6.4 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
        6.4.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
        6.4.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
    7.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
        7.2.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
        7.2.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
        7.2.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
    7.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
        7.3.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
        7.3.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
        7.3.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
    7.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
        7.4.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
        7.4.2 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
    8.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
        8.2.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
    8.3 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
        8.3.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
    8.4 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region
        8.4.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
    9.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
        9.2.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
        9.2.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
        9.2.3 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
    9.3 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
        9.3.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
        9.3.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
        9.3.3 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
    9.4 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
        9.4.1 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
        9.4.2 Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2016-2027)
    10.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
        10.2.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2027)
    10.3 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application
        10.3.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2027)
    10.4 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country
        10.4.1 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Aphios
        11.1.1 Aphios Company Details
        11.1.2 Aphios Business Overview
        11.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
        11.1.4 Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
        11.1.5 Aphios Recent Development
    11.2 Arbutus Biopharma
        11.2.1 Arbutus Biopharma Company Details
        11.2.2 Arbutus Biopharma Business Overview
        11.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
        11.2.4 Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
        11.2.5 Arbutus Biopharma Recent Development
    11.3 Camurus
        11.3.1 Camurus Company Details
        11.3.2 Camurus Business Overview
        11.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
        11.3.4 Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
        11.3.5 Camurus Recent Development
    11.4 ConjuChem
        11.4.1 ConjuChem Company Details
        11.4.2 ConjuChem Business Overview
        11.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
        11.4.4 ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
        11.4.5 ConjuChem Recent Development
    11.5 InnoCore Pharmaceuticals
        11.5.1 InnoCore Pharmaceuticals Company Details
        11.5.2 InnoCore Pharmaceuticals Business Overview
        11.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
        11.5.4 InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
        11.5.5 InnoCore Pharmaceuticals Recent Development
    11.6 LATITUDE Pharmaceuticals
        11.6.1 LATITUDE Pharmaceuticals Company Details
        11.6.2 LATITUDE Pharmaceuticals Business Overview
        11.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
        11.6.4 LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
        11.6.5 LATITUDE Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of HEPtune® Technology
    Table 3. Key Players of Intravail® Technology
    Table 4. Key Players of RapidMist™
    Table 5. Key Players of TheraKine Technology
    Table 6. Key Players of Arestat™ Technology
    Table 7. Key Players of DelSiTech™ Silica Matrix
    Table 8. Key Players of ImSus® Technology
    Table 9. Key Players of PLEX™ Technology
    Table 10. Key Players of ENHANZE® Technology
    Table 11. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 12. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 13. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (2016-2021) & (US$ Million)
    Table 14. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2016-2021)
    Table 15. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2022-2027)
    Table 17. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Trends
    Table 18. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Drivers
    Table 19. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Challenges
    Table 20. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Restraints
    Table 21. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Players (2016-2021) & (US$ Million)
    Table 22. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players (2016-2021)
    Table 23. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2020)
    Table 24. Ranking of Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Companies by Revenue (US$ Million) in 2020
    Table 25. Global 5 Largest Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue (CR5 and HHI) & (2016-2021)
    Table 26. Key Players Headquarters and Area Served
    Table 27. Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product Solution and Service
    Table 28. Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
    Table 31. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2016-2021)
    Table 32. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 33. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 34. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Share by Application (2016-2021) & (US$ Million)
    Table 35. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Application (2016-2021)
    Table 36. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 37. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 38. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
    Table 39. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
    Table 40. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
    Table 41. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
    Table 42. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
    Table 45. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
    Table 47. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million) 
    Table 49. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million) 
    Table 50. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
    Table 53. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2016-2021) & (US$ Million) 
    Table 55. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Region (2022-2027) & (US$ Million) 
    Table 56. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
    Table 57. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
    Table 59. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2016-2021) (US$ Million)
    Table 65. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2022-2027) & (US$ Million)
    Table 66. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2016-2021) & (US$ Million) 
    Table 67. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Country (2022-2027) & (US$ Million) 
    Table 68. Aphios Company Details
    Table 69. Aphios Business Overview
    Table 70. Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
    Table 71. Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
    Table 72. Aphios Recent Development
    Table 73. Arbutus Biopharma Company Details
    Table 74. Arbutus Biopharma Business Overview
    Table 75. Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
    Table 76. Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
    Table 77. Arbutus Biopharma Recent Development
    Table 78. Camurus Company Details
    Table 79. Camurus Business Overview
    Table 80. Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
    Table 81. Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
    Table 82. Camurus Recent Development
    Table 83. ConjuChem Company Details
    Table 84. ConjuChem Business Overview
    Table 85. ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
    Table 86. ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
    Table 87. ConjuChem Recent Development
    Table 88. InnoCore Pharmaceuticals Company Details
    Table 89. InnoCore Pharmaceuticals Business Overview
    Table 90. InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
    Table 91. InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
    Table 92. InnoCore Pharmaceuticals Recent Development
    Table 93. LATITUDE Pharmaceuticals Company Details
    Table 94. LATITUDE Pharmaceuticals Business Overview
    Table 95. LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product
    Table 96. LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021) & (US$ Million)
    Table 97. LATITUDE Pharmaceuticals Recent Development
    Table 98. Research Programs/Design for This Report
    Table 99. Key Data Information from Secondary Sources
    Table 100. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type: 2020 VS 2027
    Figure 2. HEPtune® Technology Features
    Figure 3. Intravail® Technology Features
    Figure 4. RapidMist™ Features
    Figure 5. TheraKine Technology Features
    Figure 6. Arestat™ Technology Features
    Figure 7. DelSiTech™ Silica Matrix Features
    Figure 8. ImSus® Technology Features
    Figure 9. PLEX™ Technology Features
    Figure 10. ENHANZE® Technology Features
    Figure 11. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application: 2020 VS 2027
    Figure 12. Delivery of Protein Case Studies
    Figure 13. Delivery of Nucleic Acids Case Studies
    Figure 14. Delivery Antibody Case Studies
    Figure 15. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Report Years Considered
    Figure 16. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 17. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions: 2020 VS 2027
    Figure 19. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2022-2027)
    Figure 20. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Players in 2020
    Figure 21. Global Top Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids as of 2020
    Figure 22. The Top 10 and 5 Players Market Share by Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue in 2020
    Figure 23. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2016-2021)
    Figure 24. Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Type (2022-2027)
    Figure 25. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
    Figure 27. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
    Figure 28. North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
    Figure 29. United States Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
    Figure 33. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
    Figure 34. Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
    Figure 35. Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. U.K. Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Nordic Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
    Figure 43. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
    Figure 44. Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Region (2016-2027)
    Figure 45. China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. South Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Australia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
    Figure 53. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
    Figure 54. Latin America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
    Figure 55. Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Type (2016-2027)
    Figure 59. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2016-2027)
    Figure 60. Middle East & Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Country (2016-2027)
    Figure 61. Turkey Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Aphios Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
    Figure 65. Arbutus Biopharma Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
    Figure 66. Camurus Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
    Figure 67. ConjuChem Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
    Figure 68. InnoCore Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
    Figure 69. LATITUDE Pharmaceuticals Revenue Growth Rate in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Aphios
Arbutus Biopharma
Camurus
ConjuChem
InnoCore Pharmaceuticals
LATITUDE Pharmaceuticals
Frequently Asked Questions
Technologies for Delivery of Proteins, Antibodies and Nucleic Acids report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Technologies for Delivery of Proteins, Antibodies and Nucleic Acids report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Technologies for Delivery of Proteins, Antibodies and Nucleic Acids report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports